| scholarly article | Q13442814 |
| P356 | DOI | 10.3727/096504017X15144755633680 |
| P698 | PubMed publication ID | 29295721 |
| P2093 | author name string | Ning Wang | |
| Tingting Zhang | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Brachytherapy in the treatment of lung cancer - a valuable solution | Q26775798 | ||
| MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling | Q27851406 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Untangling the ErbB signalling network | Q27860884 | ||
| Epidermal growth factor receptor mutations in lung cancer | Q29615474 | ||
| miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP. | Q33763354 | ||
| GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the β-catenin signaling | Q34221624 | ||
| miR-135b contributes to the radioresistance by targeting GSK3β in human glioblastoma multiforme cells | Q35284695 | ||
| High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients | Q35931599 | ||
| The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs | Q35987305 | ||
| Epidermal growth factor receptor inhibitors in cancer treatment. | Q36429442 | ||
| miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo | Q36610611 | ||
| TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells | Q36745165 | ||
| MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma | Q36863089 | ||
| microRNA-mediated regulation of the tumor microenvironment | Q37452957 | ||
| miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma | Q37482708 | ||
| Prevalence of driver mutations in non-small-cell lung cancers in the People's Republic of China. | Q37566819 | ||
| Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells | Q37638795 | ||
| MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer | Q37715770 | ||
| EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992. | Q37767383 | ||
| The 2015 WHO classification of lung tumors | Q38268008 | ||
| Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer | Q38770836 | ||
| Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation | Q38912283 | ||
| MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer | Q38994339 | ||
| MiR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells | Q39037373 | ||
| miR-135a/b modulate cisplatin resistance of human lung cancer cell line by targeting MCL1. | Q39156827 | ||
| Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. | Q39422075 | ||
| Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas. | Q40420358 | ||
| Mapping inhibitor response to the in-frame deletions, insertions and duplications of epidermal growth factor receptor (EGFR) in non-small cell lung cancer | Q41147805 | ||
| Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non-small-cell lung cancer | Q42583016 | ||
| Girdin-mediated interactions between cadherin and the actin cytoskeleton are required for epithelial morphogenesis in Drosophila | Q47071179 | ||
| Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition. | Q48150376 | ||
| Long Noncoding RNA GAS5 Inhibits Tumorigenesis and Enhances Radiosensitivity by Suppressing miR-135b Expression in Non-Small Cell Lung Cancer | Q48859003 | ||
| miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1. | Q51453851 | ||
| Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation. | Q54334379 | ||
| P921 | main subject | microRNA | Q310899 |
| P577 | publication date | 2018-01-02 | |
| P1433 | published in | Oncology Research | Q15750114 |
| P1476 | title | Down-regulation of microRNA-135 promotes sensitivity of non-small cell lung cancer to gefitinib by targeting TRIM16. |
| Q55225241 | Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer. |
| Q64068836 | Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma |
| Q91584608 | Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis |
| Q64953093 | MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma. |
| Q93147363 | Recent Findings in the Regulation of Programmed Death Ligand 1 Expression |
| Q64069885 | Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer |
| Q92221532 | The emerging treatment landscape of targeted therapy in non-small-cell lung cancer |
Search more.